
According to Benzinga Pro data, during Q3, MEI Pharma (NASDAQ:MEIP) posted sales of $9.69 million. Earnings were up 28.22%, but MEI Pharma still reported an overall loss of $8.72 million. In Q2, MEI Pharma brought in $18.22 million in sales but lost $12.16 million in earnings.